🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. agalsidase alfa

    Takeda

    Fabry Disease

    phase 3 mab completed

    3 trials

  2. alpha1-proteinase inhibitor

    Takeda

    Covid19

    phase 3 small molecule terminated

    1 trial

  3. brentuximab vedotin

    Takeda

    Hodgkin Lymphoma

    phase 3 small molecule completed

    3 trials

  4. brigatinib

    Takeda

    Non-Small Cell Lung Cancer

    phase 3 small molecule terminated

    2 trials

  5. candesartan

    Takeda

    Type 2 Diabetes

    phase 3 small molecule completed

    1 trial

  6. candesartan

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  7. candesartan cilexetil

    Takeda

    Type 1 Diabetes

    phase 3 small molecule completed

    1 trial

  8. ciclesonide

    Takeda

    Asthma

    phase 3 small molecule completed

    2 trials

  9. ciclesonide (XRP1526)

    Takeda

    Respiratory Tract Diseases

    phase 3 small molecule completed

    1 trial

  10. cyclosporine

    Takeda

    Leukemia

    phase 3 small molecule terminated

    1 trial

  11. ecallantide

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    4 trials

  12. elritercept, Placebo to match ker-050 solution for injection

    Takeda

    myelodysplastic neoplasms/syndromes (MDS)

    phase 3 small molecule active

    1 trial

  13. extended-release guanfacine hydrochloride (SPD503)

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    phase 3 small molecule completed

    1 trial

  14. hydrocortisone (modified release), oral tablet 20 and 5 mg

    Takeda

    Adrenal Insufficiency

    phase 3 small molecule completed

    1 trial

  15. icatibant

    Takeda

    Hereditary Angioedema (HAE)

    phase 3 small molecule completed

    2 trials

  16. idursulfase-IT

    Takeda

    Hunter Syndrome

    phase 3 mab active

    4 trials

  17. maribavir

    Takeda

    Cytomegalovirus Infections

    phase 3 small molecule completed

    2 trials

  18. maribavir, Maribavir, LIVTENCITY 200 mg film-coated tablets., Maribavir

    Takeda

    Cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT)

    phase 3 small molecule active

    1 trial

  19. omega-3-acid ethyl esters 90 (TAK-085)

    Takeda

    Hypertriglyceridemia

    phase 3 small molecule completed

    2 trials

  20. oxaliplatin (OXA), levofolinate calcium (l-LV), 5-FU, panitumumab

    Takeda

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial

  21. pantoprazole 20 mg (drug)

    Takeda

    Chronic Use of Acid Suppressive Medication

    phase 3 small molecule active

    1 trial

  22. peginesatide

    Takeda

    Chronic Renal Failure

    phase 3 small molecule completed

    4 trials

  23. pioglitazone

    Takeda

    Stroke

    phase 3 small molecule completed

    1 trial

  24. placebo

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources